Where does Puracath Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Puracath Medical, Inc. ranks #27,202 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Puracath Medical, Inc. hold?

Puracath Medical, Inc. holds 10 US utility patents granted between 2016 and 2025, spanning 4 technology areas.

What is Puracath Medical, Inc.'s Innovation Score?

Puracath Medical, Inc. has an Innovation Score of 36.0 out of 100 (top 48% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Puracath Medical, Inc.'s patent grant rate increasing or decreasing?

Puracath Medical, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Puracath Medical, Inc.'s patents?

Puracath Medical, Inc.'s patents average 23.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Puracath Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Puracath Medical, Inc.

Q: What technology areas does Puracath Medical, Inc. focus on?

Puracath Medical, Inc.'s top technology area is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles) with 10 patents. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Puracath ranks #27,202 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 4 technology areas.

#27,202
of 49,997 US assignees by volume: Top 48%
by Innovation Score (36.0/100): 23.3
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27202 · US Corporation #27,202 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,202/49,997
PHOTO-FINISH Pablo
CPC-NARROW A61L · 4 areas
INNOV-THIN 36.0/100
CLAIMS-DENSE 23.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pablo, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Puracath Medical · this assignee

36
3D Lighting… · lowest

7

What this shows Puracath's Innovation Score is 36.0/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Puracath's grants concentrate

Puracath Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2022. By volume, Puracath sits between Proxy Biomedical Limited and Pacific Coast Building Products, Inc..

Puracath's three-year grant acceleration

Puracath Medical, Inc. shows 3 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Proxy Biomedical

10
Psivida US

10
PSP

10
PTT Exploration a…

10
Pyxis CF PTE

10
Pablo

10
Pacific Bearing

10
Pacific Coast Bui…

10
Puracath Medical ◀

10

What this shows Puracath holds 10 patents at rank #27,121, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Puracath

By rank, the assignees closest to #27,121 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Puracath's primary technology class.

Puracath's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Puracath Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	20.0%
2021	3	30.0%
2022	1	10.0%
2023	1	10.0%
2024	1	10.0%
2025partial year	2	20.0%

Which technologies does Puracath Medical, Inc. patent most?

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 10

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 9

A61B - DIAGNOSIS; SURGERY; Identification 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 4 of 4 technology areas

Where it ranks

Overall rank by patents

#27,202

of 49,997 tracked assignees

Innovation Score

36.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Puracath Medical, Inc.'s patent record in context - here's where to go next.

Puracath Medical, Inc.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 100% of its portfolio - see every assignee active in that class. Explore A61L
Ranked #27,202 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Puracath Medical, Inc. against Proxy Biomedical Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.